医学
Paper Review Records
全部论文审稿周期
14 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
Pharmacokinetics, Safety, and Dosing of Antiseizure Medications in Patients with Renal or Hepatic Impairment
作者Jingheng Wu; Miaomiao Li; Shuai Wang
作者单位1. Department of Functional Neurosurgery of Shengjing Hospital, China Medical University, Shenyang, China; 2. Huanhu Hospital Affiliated to Tianjin Medical University, Tianjin, China; 3. Tianjin Key Laboratory of Cerebral Blood Flow Reconstruction and Head and Neck Tumor New Technology Translation, Tianjin Neurosurgical Institute, Tianjin Huanhu Hospital, Tianjin, China; 4. Liaoning Clinical Medical Research Center in Nervous System Disease, Shenyang, China; 5. Shenyang, China
How Feasible is the Use of Saliva for Antiviral Therapeutic Drug Monitoring? A Systematic Review and Analysis
作者Cassandra Weng-Yan Lai; Suzanne A. M. Wenker; Paul W. Groundwater; Justin Beardsley; Gaurav Sutrave; Ricky Hao Chen; Anne-Grete Märtson; Jan-Willem C. Alffenaar
作者单位1. School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; 2. Faculty of Science, Leiden Academic Centre for Drug Research, Leiden University, Leiden, Netherlands; 3. Sydney Institute for Infectious Diseases, University of Sydney, Sydney, Australia; 4. Department of Infectious Diseases, Westmead Hospital, Westmead, Australia; 5. Sydney Medical School-Westmead, University of Sydney, Sydney, Australia; 6. Department of Hematology, Westmead Hospital, Westmead, Australia; 7. Department of Pharmacy, Westmead Hospital, Westmead, Australia
Exposure–Response Analyses to Inform the Optimal Epcoritamab Monotherapy Dosing Regimen in Relapsed or Refractory Follicular Lymphoma
作者Mahipal Sinnollareddy; Kinjal Sanghavi; Leonid Gibiansky; Tommy Li; Matthew Putnins; Mohamed-Eslam F. Mohamed; Poliana Patah; Elena Favaro; Manish Gupta; Apurvasena Parikh; Steven Xu
作者单位1. Clinical Pharmacology, AbbVie Inc., North Chicago, USA; 2. Clinical Pharmacology, AbbVie Inc., Irvine, USA; 3. Genmab, Plainsboro, USA; 4. QuantPharm LLC, North Potomac, USA; 5. Genmab, Copenhagen, Denmark; 6. Clinical Pharmacology, AbbVie Inc., South San Francisco, USA
Simulation-Based Predictions to Support the Development of a Pediatric Fixed-Dose Combination of Dolutegravir/Emtricitabine/Tenofovir Alafenamide Fumarate
作者Hylke Waalewijn; Lisanne A. H. Bevers; Linda L. Lewis; Margaret D. Louey; Sonoko Kawakatsu; Yanan Zheng; Carlo Giaquinto; Alessandra Nardone; David M. Burger; Rob ter Heine; Angela Colbers; Elin M. Svensson
作者单位1. Department of Pharmacy, Pharmacology and Toxicology, Radboud Institute for Medical Innovation (RIMI), Radboud University Medical Center, Nijmegen, The Netherlands; 2. Product Development, Quality, Costing and Regulatory Affairs, Clinton Health Access Initiative, Boston, USA; 3. Gilead Sciences, Inc., Foster City, USA; 4. Fondazione Penta ETS, Padova, Italy; 5. Department of Pharmacy, Uppsala University, Uppsala, Sweden
Physiologically Based Pharmacokinetic Modeling of Vedolizumab in Healthy Adults and Patients with Inflammatory Bowel Disease
作者Sanjana Parikh; Kei Irie; Ryota Tanaka; Takanobu Nadai; Phillip Minar; Tomoyuki Mizuno
作者单位1. Division of Translational and Clinical Pharmacology, Cincinnati Children’s Hospital Medical Center, Cincinnati, USA; 2. Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, USA; 3. Department of Clinical Pharmacy, Oita University Hospital, Yufu, Japan; 4. Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children’s Hospital Medical Center, Cincinnati, USA; 5. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, USA
Population Pharmacokinetics of Bosutinib in Children with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Based on a Phase I Dose-Finding Trial (ITCC-054/COG AAML1921) and Pediatric Recommended Phase II Dosage Evaluation
作者Jen-Hao Wu; Francisco Bautista; Erica Brivio; Marieke Willemse; Karey Kowalski; Brian Jermain; May Garrett; Andrew Bukowinski; Carmelo Rizzari; Jessica Pollard; Laura Murillo-Sanjuán; Matthew Kutny; Sara Zarnegar-Lumley; Michele Redell; Stacy Cooper; Yves Bertrand; Arnaud Petit; Julie Krystal; Markus Metzler; Donna Lancaster; Jean-Pierre Bourquin; Jayashree Motwani; Inge M. van der Sluis; Franco Locatelli; Michael E. Roth; Nobuko Hijiya; C. Michel Zwaan; Alwin D. R. Huitema
作者单位1. Department of Pediatric Oncology, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands; 2. Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; 3. Pfizer Inc, La Jolla, USA; 4. UPMC Children’s Hospital of Pittsburgh, Pittsburgh, USA; 5. Pediatric Hematology and Oncology Unit, IRCCS San Gerardo dei Tintori, Monza, Italy; 6. Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Harvard Medical School, Boston, USA; 7. Hospital Universitari Vall d’Hebron, Barcelona, Spain; 8. Pediatric Hematology/Oncology, University of Alabama at Birmingham, Birmingham, USA; 9. Ann & Robert H. Lurie Children’s Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, USA; 10. Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, USA; 11. Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, USA; 12. CHU Lyon/Hospices Civils de Lyon, Lyon, France; 13. Armand Trousseau Hospital, APHP, Sorbonne Université, Paris, France; 14. The Steven and Alexandra Cohen Children’s Medical Center of New York, New York, USA; 15. Universitätsklinikum Erlangen, Erlangen, Germany; 16. The Royal Marsden NHS Foundation Trust, London, UK; 17. University Children’s Hospital, Zürich, Switzerland; 18. Birmingham Children’s Hospital, Birmingham, UK; 19. IRCCS Ospedale Pediatrico Bambino Gesù, Catholic University of the Sacred Heart, Rome, Italy; 20. University of Texas M. D. Anderson Cancer Center, Houston, USA; 21. Columbia University Irving Medical Center, New York, USA; 22. Department of Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands; 23. Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
Pharmacometric Targets During Anti-TNF Induction and Their Association with Deep Remission in Pediatric Crohn’s Disease
作者Alexander Nasr; Tomoyuki Mizuno; Kei Irie; Jonathan R. Dillman; Kimberly Jackson; Kimberly Lynch; Alexa Horrell; Thomas Aviles; Kelly Chun; Jane Yang; Brendan Boyle; Jeffrey S. Hyams; Joshua Noe; Lee. A. Denson; Phillip Minar
作者单位1. Division of Pediatric Gastroenterology, Hepatology and Nutrition, Cincinnati Children’s Hospital Medical Center, Cincinnati, USA; 2. University of Cincinnati College of Medicine, Cincinnati, USA; 3. Division of Clinical Pharmacology, Cincinnati Children’s Hospital Medical Center, Cincinnati, USA; 4. Department of Radiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, USA; 5. Esoterix, LabCorp Specialty Lab, Calabasas, USA; 6. Division of Pediatric Gastroenterology, Hepatology and Nutrition, Nationwide Children’s Hospital, Columbus, USA; 7. Division of Digestive Diseases and Nutrition, Connecticut Children’s Medical Center, Hartford, USA; 8. Division of Pediatric Gastroenterology, Medical College of Wisconsin, Milwaukee, USA
Low Tacrolimus C 0 /Dose Ratio is Associated with Higher C max and AUC Despite Similar Pre-dose Concentrations
作者Amar D. Levens; Teun van Gelder; Armin Gelinck; Soufian Meziyerh; Aiko P. J. de Vries; Danny van der Helm; Jesse J. Swen; Dirk Jan A. R. Moes
作者单位1. Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands; 2. Leiden Transplant Center, Leiden University Medical Center and Leiden University, Leiden, The Netherlands; 3. Division of Nephrology, Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands
A Review of Population Pharmacokinetic Models and Dosing Algorithms Assessing the Influence of CYP3A5 Genotype and Other Clinical Covariates on Tacrolimus Pharmacokinetics
作者Riley M. Randolph; Sara Jubas; Li Gong; Raman Venkataramanan; Dhrita Khatri; Pamala A. Jacobson; David Metz; Daniel J. Crona
作者单位1. Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, USA; 2. Department of Biomedical Data Science, Stanford University, Stanford, USA; 3. Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, USA; 4. Cancer Therapies, Stem Cell Medicine, Murdoch Children’s Research Institute, Parkville, Australia; 5. Department of Paediatrics, The University of Melbourne, Parkville, Australia; 6. Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, USA; 7. Department of Nephrology, Royal Children’s Hospital, Melbourne, Australia; 8. Department of Paediatrics, Monash University, Melbourne, Australia; 9. Murdoch Children’s Research Institute, Melbourne, Australia; 10. Monash Children’s Hospital, Monash Health, Melbourne, Australia; 11. Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, USA; 12. Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。